Mylan, IRS Trade Opening Shots Ahead Of $100M Tax Trial
Mylan and the IRS have exchanged opening salvos in a $100 million tax fight relating to its transaction with Forest Laboratories Holdings Ltd. over the anti-hypertensive compound nebivolol, submitting dueling briefs...To view the full article, register now.
Already a subscriber? Click here to view full article